Clinical Trial: A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590167) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C' on May 11.

Brief Summary: A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Dyslipidemia Hypertension

Intervention: DRUG: AD-231

AD-231 Oral Tablet

DRUG: AD-231A, AD-231D and AD-231C

AD-231A Oral Tablet + AD-231D Oral Tablet + AD-231C Oral Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Published by HT Digital Content Services with permissio...